Docetere Rfa 120 MG Injection 1

Docetere Rfa 120 MG Injection 1 is used for the following:

• Management of breast cancer

• Controlling non-small cell lung cancer

• Helping to control prostate cancer

• Assisting in controlling stomach cancer

• Helping to manage head and neck cancer

Here's how you should administer Docetere Rfa 120 MG Injection 1:

• The injection is administered by a healthcare professional only.

• It is given intravenously, which means it is injected into your vein.

• This usually happens in a hospital or clinic setting.

• The process typically lasts for about 1 hour.

• If you have any queries or doubts, do not hesitate to consult your doctor.

Docetere Rfa 120 MG Injection 1 is administered intravenously.

Docetere Rfa 120 MG Injection 1 contains docetaxel (120mg). It works on the body as follows:

• Microtubule Interference: Docetaxel disrupts the structures within cancer cells known as microtubules, which are vital for cancer cell division and multiplication.

• Slowing Cancer Cell Growth: By disrupting the microtubules, docetaxel slows down the growth of cancer cells. This helps to manage the progression of the cancer.

• Inducing Cancer Cell Death: Disrupting the microtubules not only slows the growth of cancer cells but can also lead to their death. This action further aids in the management of various types of cancer.

• Keep Docetere Rfa 120 MG Injection 1 at room temperature.

• Protect it from excessive light and moisture.

• Always store this medicine in a safe place where children cannot reach it.

• Remember to check the expiry date before administering the injection.

• If you're using Docetere Rfa 120 MG Injection 1 for breast or prostate cancer, maintaining a balanced diet rich in fruits, vegetables, lean proteins, and whole grains can support your overall health during treatment.

• Regular light exercise, like walking or yoga, can help manage fatigue and weakness often associated with chemotherapy. Remember to consult your doctor before starting any new exercise regime.